Not available
Quote | Adaptimmune Therapeutics plc (NASDAQ:ADAP)
Last: | $1.58 |
---|---|
Change Percent: | -4.43% |
Open: | $1.65 |
Close: | $1.58 |
High: | $1.65 |
Low: | $1.53 |
Volume: | 1,066,310 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
News | Adaptimmune Therapeutics plc (NASDAQ:ADAP)
Philadelphia, Pennsylvania and Oxford, United Kindgom--(Newsfile Corp. - March 27, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining the treatment of solid tumor cancers with cell therapy, today announced that The Lancet published the company's pivotal Phase 2 data with ...
2024-03-07 13:13:56 ET More on Adaptimmune Adaptimmune Therapeutics plc (ADAP) Q4 2023 Earnings Call Transcript Adaptimmune: Drug Approval Now Imminent? FDA accepts Adaptimmune BLA for afami-cel, decision expected by Aug. 4 Adaptimmune projects sarcoma franch...
Message Board Posts | Adaptimmune Therapeutics plc (NASDAQ:ADAP)
Subject | By | Source | When |
---|---|---|---|
ASCO The SPEARHEAD-1 trial of afamitresgene autoleucel (afami-cel [formerly | jondoeuk | investorshub | 04/30/2023 5:33:59 PM |
From FB https://www.fiercepharma.com/pharma/astellas-writes-340m-fibrogens-evren | jondoeuk | investorshub | 04/14/2023 1:08:05 AM |
The company said it will regain rights to | jondoeuk | investorshub | 04/11/2023 6:54:34 PM |
Upcoming https://annualmeeting.asgct.org/program/agenda-details?agendaId=26880 | jondoeuk | investorshub | 04/10/2023 5:52:14 PM |
(OT) Two interesting preclinical papers https://jitc.bmj.com/content/11/4/e00551 | jondoeuk | investorshub | 04/05/2023 8:56:43 PM |
News, Short Squeeze, Breakout and More Instantly...
Adaptimmune Therapeutics plc Company Name:
ADAP Stock Symbol:
NASDAQ Market:
Philadelphia, Pennsylvania and Oxford, United Kindgom--(Newsfile Corp. - March 27, 2024) - Adaptimmune Therapeutics plc (NASDAQ: ADAP), a company redefining the treatment of solid tumor cancers with cell therapy, today announced that The Lancet published the company's pivotal Phase 2 data with ...
Shares of Marvell Technology, Inc. (NASDAQ: MRVL) fell sharply during Friday’s session after the company reported fourth-quarter financial r...
U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Friday. Shares of Smith & Wesson Brands, Inc. (NASDAQ: SWBI)...